➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Baxter
Harvard Business School
Merck
Moodys

Last Updated: October 22, 2020

DrugPatentWatch Database Preview

Details for Patent: 9,480,652

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,480,652 protect, and when does it expire?

Patent 9,480,652 protects VARITHENA and is included in one NDA.

This patent has eight patent family members in eight countries.

Summary for Patent: 9,480,652
Title:Aerosol valve
Abstract: A steam-sterilizable aerosol valve has a valve body of polymeric material such as polyphenylene sulfone (PPSU) having an HDT (heat deflection temperature) at 1.8 MPa stress in the range of 200-275.degree. C. Such a valve has the ability to survive steam sterilization without significant degradation of properties or appearance.
Inventor(s): Harman; Anthony David (Henley-on-thames, GB)
Assignee: BTG INTERNATIONAL LIMITED (London, GB)
Application Number:12/083,871
Patent Claim Types:
see list of patent claims
Device; Compound; Use; Composition; Formulation;

Drugs Protected by US Patent 9,480,652

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Provensis VARITHENA polidocanol SOLUTION;INTRAVENOUS 205098-001 Nov 25, 2013 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,480,652

PCT Information
PCT FiledOctober 20, 2006PCT Application Number:PCT/GB2006/003916
PCT Publication Date:April 26, 2007PCT Publication Number: WO2007/045897

International Family Members for US Patent 9,480,652

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 509863   Start Trial
Cyprus 1112530   Start Trial
Denmark 1945533   Start Trial
European Patent Office 1945533   Start Trial
Spain 2366399   Start Trial
Poland 1945533   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
McKesson
Harvard Business School
Medtronic
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.